Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 100
- CBD Market
UK’s CBD Industry Poised for Takeoff: FSA Clears Skies for New Products
BRITISH CANNABIS™ Submits Article 4 Application for Non-Novel Status of a Cannabis Ingredient and Receives a Preliminary Green Light.
- Uncategorized
Majority of Florida Voters in Favour of Cannabis Legalization
More than two-thirds of registered voters in Florida would back the legalization of adult-use cannabis in the state, according to a new poll from the University of North Florida (UNF).
- Markets & Stocks
Jazz Pharma’s Epidiolex Approved in Canada, Apollon Nears Take Over Deal, & Stenocare Expands in Australia
Jazz Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”JAZZ” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Epidiolex (Epidyolex in the EU and UK), Jazz Pharmaceuticals’ market leading cannabis-based medication, has received authorisation to be prescribed for a number of conditions in Canada.
- Adult-Use
Ohio Republican Lawmakers Aim to Divert Cannabis Taxes Away From Social Equity Programmes
Ohio’s Governor Mike DeWine, alongside other Republican lawmakers have introduced a new bill aiming to alter the state’s landmark adult-use legalization bill.
- Adult-Use
Leaked Documents Suggest Significant Changes to Germany’s Cannabis Act
Germany’s traffic light coalition has reportedly agreed on a number of significant changes to the country’s landmark cannabis act.
- Uncategorized
Durchgesickerte Dokumente deuten auf signifikante Änderungen des deutschen Cannabisgesetzes hin
Die Ampelkoalition in Deutschland hat sich Berichten zufolge auf eine Reihe wichtiger Änderungen an dem bahnbrechenden Cannabisgesetz des Landes geeinigt.
- Uncategorized
New York Cannabis Regulators Approve Settlement of 2 Lawsuits
New York’s cannabis industry, which has been stuck in a legal quagmire for months, may now be able to progress as regulators voted to approve a settlement agreement yesterday.
- Press releases
BZAM Ltd. & 4C Labs Conclude Strategic Distribution Agreement for the UK Market
BZAM Ltd. (the “Company” or “BZAM”) (CSE: BZAM) (US-OTC:BZAMF), is pleased to announce that its subsidiary, The Green Organic Dutchman Ltd. (collectively the “Company”) has completed its first shipment of Canadian certified organic, EU GMP medical flowers to the UK.
- Uncategorized
Hemp Farmers Are Losing Their Licenses After Growing Cannabis
Hemp farmers across the United States are seeing their licenses revoked by the US Department of Agriculture (USDA) amid a lack of legal and regulatory clarity.
- Medical
Rokshaw Announces Launch of Four20 Medical Cannabis Products in the UK
Rokshaw can today announce the exclusive UK manufacture and distribution of medical cannabis products under the Four20 Pharma brand.
- Uncategorized
DEA-Registered Bright Green Corporation Posts Q3 Figures
Bright Green, one of the few companies eligible for authorisation to grow, manufacture and sell cannabis under both Federal and state laws, this week reported its Q3 figures.
- Medical
Ukraine’s Medical Cannabis Legalisation Delayed by Opponents
Ukraine’s bid to legalise medical cannabis appeared to be on the cusp of a significant breakthrough this week, but defeat was snatched from the jaws of victory and the bill has now been effectively ‘blocked’.











